He is interested in personalized medicine with respect to the understanding of the progression and treatment of cancer. His lab leverages a multidisciplinary approach to understanding genetic and non-genetic drivers of cancer and metastasis, specifically focusing on cholesterol metabolism, intertumor and intratumor heterogeneity, and regulators of the stem cell phenotype.